adamantane has been researched along with Anochlesia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanova, EA; Kapitsa, IG; Val'dman, EA; Voronina, TA | 1 |
| Borea, PA; Canazza, I; De Luca, MA; Di Rosa, F; Fantinati, A; Gregori, A; Margiani, G; Marti, M; Ossato, A; Rimondo, C; Serpelloni, G; Trapella, C; Varani, K; Vincenzi, F | 1 |
| Casti, P; Casu, G; Marchese, G; Pani, L; Ruiu, S | 1 |
| Binder, EB; Kinkead, B; Nemeroff, CB; Owens, MJ | 1 |
| Hasegawa, S; Nakazono, M; Yamamoto, T; Zaitsu, K | 1 |
| Bondavalli, F; Lampa, E; Mariani, E; Marmo, E; Schenone, P | 1 |
| Gmiro, VE; Gorbunova, LV; Lukomskaia, NIa; Rukoiatkina, NI | 1 |
7 other study(ies) available for adamantane and Anochlesia
| Article | Year |
|---|---|
Anti-Parkinsonian Activity of Hemantane on a Model of Hemiparkinsonian Syndrome in Rats.
Topics: Adamantane; Animals; Antiparkinson Agents; Catalepsy; Levodopa; Male; Rats; Rats, Wistar | 2015 |
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Topics: Adamantane; Aggression; Animals; Behavior, Animal; Binding, Competitive; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabis; Catalepsy; Dopamine; Dronabinol; Humans; In Vitro Techniques; Indazoles; Indoles; Male; Mice; Motor Activity; Naphthalenes; Nucleus Accumbens; Pain Threshold; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Abnormal; Seizures | 2016 |
Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
Topics: Adamantane; Analysis of Variance; Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Imidazoles; Injections, Intraperitoneal; Male; Mice; Motor Activity; Pyrazoles; Quinolines; Receptors, Neurotensin | 2004 |
Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
Topics: Adamantane; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Catalepsy; Cell Count; Dose-Response Relationship, Drug; Drug Interactions; Imidazoles; Immunohistochemistry; Male; Neostriatum; Oncogene Proteins v-fos; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Neurotensin; Time Factors | 2004 |
Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice.
Topics: Adamantane; Animals; Catalepsy; Fullerenes; Haloperidol; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Molecular Structure | 2004 |
(+/-)-1-(Adamantan-2-yl)-2-propanamine and other amines derived from 2-adamantanone.
Topics: Acetylcholine; Adamantane; Animals; Antiparkinson Agents; Catalepsy; Chemical Phenomena; Chemistry; Female; Humans; Male; Mice; Motor Activity; Pregnancy; Tremor | 1980 |
[Glutamate receptor antagonists attenuate experimental catalepsy in rats].
Topics: Adamantane; Animals; Antipsychotic Agents; Ataxia; Catalepsy; Diamines; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Haloperidol; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Stereotyped Behavior | 2000 |